Modeling Center of Excellence Practices to Improve the Care of Patients With Biomarker-Driven Thyroid Cancer or Non-Small-Cell Lung Cancer

Interactive Practice Guide

Biomarker testing is key to unlocking the potential of precision medicine. Are your molecular testing procedures optimized to guide treatment for your patients with advanced NSCLC or thyroid cancer?

Assess your current practices, review the latest evidence and best practices shared by leaders in the field, and create a plan to optimize testing and treatment selection practices to ensure your patients are benefitting from the latest advancements in biomarker testing and precision medicine. Different education pathways are available for thyroid cancer, NSCLC, and a focus on molecular pathology in both tumor types. Use these materials on your own or to facilitate scenario-based learning and action planning with your team to improve biomarker testing practices.

Faculty: Maria Arcila, MD; Marcia Brose, MD, PhD, FASCO; Lori Wirth, MD

Release Date: January 31, 2024

Expiration Date: January 31, 2025

CME/CE is no longer available for this activity